ATRT is a rare, aggressive childhood brain cancer. Research is essential to developing more effective treatments, improving survival, and reducing the long-term effects of treatment.
Today’s treatment is harsh and largely outdated. Babies like Rowen go through months of intensive chemotherapy, brain surgery, and sometimes radiation — and most of the chemo drugs in his plan were first developed between the 1950s and the 1980s. Because childhood cancers are rare, very few new drugs are made with children in mind.
Supporting research helps give children diagnosed today—and those diagnosed in the future—more options and more hope.